[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341670-105":3,"doc-detail-341670-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","triage-performance-of-pax1mjam3m-in-opportunistic-cervical-cancer-screening-of-non-1618-human-papillomavirus-positive-women-a-multicenter-prospective-study-in-china","Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non-16/18 human papillomavirus-positive women - a multicenter prospective study in China","","Validating PAX1m/JAM3m methylation testing as a triage tool for detecting CIN3+ in non-16/18 high-risk HPV-positive women, this multicenter prospective study compares triage performance against liquid-based cytology (LBC). Among 1851 participants with cervical histology outcomes, LBC ≥ ASCUS shows 90.1%/26.7% sensitivity/specificity, while PAX1m/JAM3m shows 84.8%/88.5%. PAX1m/JAM3m(+) achieves the highest diagnostic AUC (0.866). It detects all cancers (n=20) and reduces colposcopy referrals versus LBC ≥ ASCUS by 57.21%, with preserved diagnostic sensitivity despite reduced specificity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/triage-performance-of-pax1mjam3m-in-opportunistic-cervical-cancer-screening-of-non-1618-human-papillomavirus-positive-women-a-multicenter-prospective-study-in-china/341670/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/triage-performance-of-pax1mjam3m-in-opportunistic-cervical-cancer-screening-of-non-1618-human-papillomavirus-positive-women-a-multicenter-prospective-study-in-china/341670.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What triage target does the PAX1m/JAM3m test aim to detect?","Question",{"text":63,"@type":64},"The study validates PAX1m/JAM3m as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3+).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PAX1m/JAM3m perform compared with LBC ≥ ASCUS?",{"text":68,"@type":64},"PAX1m/JAM3m shows 84.8% sensitivity and 88.5% specificity, while LBC ≥ ASCUS shows 90.1% sensitivity and 26.7% specificity.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the effect of PAX1m/JAM3m(+) on colposcopy referrals?",{"text":72,"@type":64},"Compared with LBC ≥ ASCUS, PAX1m/JAM3m(+) reduced the number of patients needing referral for colposcopy by 57.21%.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341670,1790129853,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"Chen et al. Clinical Epigenetics (2024) 16:108 [https://doi.org/10.1186/s13148-024-01731-w](https://doi.org/10.1186/s13148-024-01731-w)  \nClinical Epigenetics  \n RESEARCH Open Access  \nTriage performance of PAX1m/JAM3m  in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China  \nXiaojing Chen1,2,3, Xitong Jin4, Linghua Kong1,2,3, Yuligh Liou4,5, Pei Liu4, Zhe Dong6, Sijun Zhou7, Bingli Qi8, Jing Fei9, Xiaoyan Chen10, Guangwu Xiong6, Yuchong Hu7, Shikai Liu8, Jianwei Zhou9, Huafeng Shou10 and Lei Li 1,2,3*  \nAbstract  \nObjectives In this study, we aimed to validate the performance of the PAX1 and JAM3 methylation (PAX1m/JAM3m) test as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) in non-16/18 high-risk human papillomavirus-positive patients (non-16/18 hrHPV +) .  \nMethods The triage performance of liquid-based cytology (LBC) and the PAX1m/JAM3m test for detecting CIN3 + were compared.  \nResults In total, 1851 participants had cervical histological outcomes and were included in the analysis. The sensitivity/specificity of the LBC test results with atypical squamous cells of undetermined significance or worse (LBC ≥ ASCUS) and the PAX1m/JAM3m test were 90 . 1%/26 . 7% and 84 . 8%/88 . 5%, respectively. PAX1m/JAM3m( +) had the highest diagnostic AUC (0 . 866, 95% confidence interval (CI) 0.837–0. 896) in the whole cohort. All cancers (n = 20) were detected by PAX1m/JAM3m(+) . Compared with LBC ≥ ASCUS, PAX1m/JAM3m(+) reduced the number of patients who needed referral for colposcopy by 57 . 21%(74 . 66% vs. 17.45%) . The odds ratios for detecting CIN3 + by LBC ≥ ASCUS and PAX1m/JAM3m(+) were 3.3 (95% CI 2 .0–5. 9) and 42.6 (27 .1–69. 6), respectively (p \u003C 0. 001) . The combination of LBC ≥ ASCUS or PAX1m/JAM3m(+) slightly increased the diagnostic sensitivity (98 . 0%, 95% CI: 95 . 8–100%) and referral rate (77 . 09%) but reduced the diagnostic specificity (24 . 8%, 22 .7–26. 8%) .  \nConclusions In non-16/18 hrHPV(+) women, PAX1m/JAM3m was superior to cytology for detecting CIN3 + . Compared with LBC ≥ ASCUS, PAX1m/JAM3m(+) reduced the number of significant referrals to colposcopy without compromising diagnostic sensitivity.  \nKeywords Cervical cancer, Cervical intraepithelial lesions, Human papillomavirus DNA tests, Liquid-based cytology, DNA methylation, Non-16/18-type high-risk human papillomavirus infections  \n*Correspondence: Lei Li[lileigh@163.com](lileigh@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nChen et al. Clinical Epigenetics (2024) 16:108  \nIntroduction  \nCervical cancer (CC) is a major public health issue affecting women globally and ranks fourth among cancers causing fatalities in females [1]. With advancements in vaccination, sc","cbCaikDKVfc7pFto","https://ap.wps.com/l/cbCaikDKVfc7pFto","pdf",1092454,9,"English","# Introduction\n## HPV screening limitations and guideline approaches\n## Rationale for methylation-based triage\n# Objectives\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What triage target does the PAX1m/JAM3m test aim to detect?\",\"answer\":\"The study validates PAX1m/JAM3m as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3+).\"},{\"question\":\"How does PAX1m/JAM3m perform compared with LBC ≥ ASCUS?\",\"answer\":\"PAX1m/JAM3m shows 84.8% sensitivity and 88.5% specificity, while LBC ≥ ASCUS shows 90.1% sensitivity and 26.7% specificity.\"},{\"question\":\"What was the effect of PAX1m/JAM3m(+) on colposcopy referrals?\",\"answer\":\"Compared with LBC ≥ ASCUS, PAX1m/JAM3m(+) reduced the number of patients needing referral for colposcopy by 57.21%.\"}]","Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non-16/18 human papillomavirus-positive women - a multicenter prospective study in China | PDF",1790043129,23,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce444a3cafbbca84d2a3cfafd296afd2.webp",983,1305,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9e3dbc26e0f7d45d887492605b1a30a.webp",982,1304,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9249f3346cc07323c5a9469bb7dcfb95.webp",981,1303,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c604fb7a2344053c78b1a3559859197.webp",980,1301,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]